Member Info for Mozax

Furthermore, anyone that has held here for more than a few months will know The Company is being BID for, by more than one suitor.

The general focus here has been related to the ‘KidneyintelX.dkd & its its use in testing for chronic kidney disease.

Whilst the information has always been available that our technology covers type 2 diabetes todays news emphasises an enormous market that has yet to be tapped.

17p will be swiftly in the rear view mirror, and the potential here is massive.

This will move so fast on the announcement of decent user numbers & uptake from the US.

AT holds so much stock there must be very little freefloat.

Although it took over 2 months to notify…..🙄

Harwood Capital increasing.

HE1 MCap currently £72M

JAY MCap barely £7M.

JAY will blast off with the next update, our assets are phenomenal.

I didn’t attend the AGM but would be very pleased if this is the case, indeed, there could be some major announcements in the near future.

Well, I’ve accepted that the £2Billion AUM by ‘2025’ could well mean by the end of 2025, or at some point during it.

There have been a number of references by the Company that they will exceed this figure, and constant reinforcement that in any case, it will be achieved.

It’s only 18 months, or potentially much less, until the Company will be making significant revenues on that figure.

However, What’s truly interesting, is that we are rapidly nearing a point whereby the Company will need to add £100M a month in AUM to reach their constantly acknowledged & reiterated target.

Interesting price action, .75p easily reached on low volume, suggests recent buying activity has gone to ‘sticky hands’ as holders see huge potential here.

And of course, there is huge potential, this Company, working with Global Giants, has the opportunity to create some serious wealth for the patient.

Well, some profits will come across from HE1 MCap £55M to JAY MCap £7.5M with a substantial diversified portfolio of assets including Helium/Hydrogen.

With the squeeze on Copper resources and potential further surge in prices it’s good to be invested in a Company with this sort of diversification.

Money went over to HE1 which is up 23%, putting more value on their MCap/ Helium asset is only good for JAY.

HE1 now £55M MCap - JAY only £7.5M……just be patient.

Currently valued at less than cash in the bank.

Will continue to build.

JAY was off the radar to most investors until the Helium/Hydrogen RNS.

Since then, the market has analysed the vast potential of the Company.

Buy, and hold.

Simple.

Remember, with the licences that JAY hold, the investment already made (£125M on just one license) and recent discoveries with fast track potential due to a plethora of existing drill holes, the current MCap is laughable.

It wouldn’t surprise me to see one of the bigger players just take this out.

Recent financial report states no equity capital required. ( No Placing).

They won’t be ‘burning through cash’ when the business is generating significant income, compared to MCap.

£7.42 M in cash.

The business is cash generative on current AUM $700M.

No debt - this has been paid off.

Plus Unilever partnership bubbling away in the background.

We’re certainly working with some significant Companies.

Just non stop waffle here.

Why don’t any of you post a few worthwhile links demonstrating the value of our existing licences, the vast Copper reserves for example.

The Helium & Hydrogen RNS is additional to an already highly undervalued Company.

And yes, our Partnership with Kobold is backed by powerful Global investors who are rather well known.

Here, Is under £10M.

Don’t worry about the short term share price movements, look at how cheap this Company is!!

Buy & Hold and wait for the real value.

Just a small amount of research and ‘investors’ can see the value of the licences and huge potential here.

Get them in the ISA and leave them there.

WSJ: Bill Gates on His Climate Investments: The Early Winners and Long Shots

In an interview with the Wall Street Journal on his climate-related investments, Bill Gates “predicted success for KoBold Metals.”

Bluejay is listed on the London AIM market and Frankfurt Stock Exchange and its shares also trade on the Pink Market in the US. With multiple projects in Greenland and Finland, Bluejay offers both portfolio and commodity diversification focused on base and precious metals in Tier 1 jurisdictions.

Bluejay, through its wholly owned subsidiary Disko Exploration Ltd., has signed a definitive Joint Venture Agreement with KoBold Metals to guide exploration for new deposits rich in the critical materials required for the green energy transition and electric vehicles (the Disko-Nuussuaq nickel-copper-cobalt-PGE Project). This project is Bluejay's primary focus.

Now, add in todays news.